← All companies
Avidity Biosciences, Inc.
RNA - CIK 0001599901
Market cap$1.81 B
Rank#2174
SEC filings547
The table below shows Avidity Biosciences, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $382.52M | $219.87M | $185.08M | $340.40M | $320.45M | $321.46M |
| Short-term investments | - | - | - | - | $85.09M | $6.68M |
| Receivables | - | $0.00 | $1.10M | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.